Investors React Positively To Data From Orphazyme's Neurodegenerative Disease CandidateBenzinga • 08/23/21
Orphazyme announces publication of results from its Phase 2/3 trial of arimoclomol in Niemann-Pick disease type C in the Journal of Inherited Metabolic DiseaseGlobeNewsWire • 08/23/21
Rosen, A Leading Law Firm, Encourages Orphazyme A/S Investors with Losses in Excess of $100K to Secure Counsel Before Important September 7 Deadline in Securities Class Action - ORPHNewsfile Corp • 08/20/21
ORPH NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Orphazyme A/S Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ORPHPRNewsWire • 08/17/21
Rosen, Top Ranked Investor Counsel, Encourages Orphazyme A/S Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ORPHNewsfile Corp • 08/14/21
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Orphazyme A/S (ORPH)PRNewsWire • 08/13/21
Do Options Traders Know Something About Orphazyme (ORPH) Stock We Don't?Zacks Investment Research • 08/11/21
ORPH Breaking News: Rosen, Top Ranked National Investor Attorneys, Encourages Orphazyme A/S Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - ORPHNewsfile Corp • 08/06/21
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Orphazyme A/S (ORPH) InvestorsPRNewsWire • 08/04/21
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Orphazyme A/S Investors With Losses Exceeding $100K to Secure Counsel Before Important September 7 Deadline in Securities Class Action – ORPHBusiness Wire • 08/03/21
Rosen, Trusted National Trial Counsel, Encourages Orphazyme A/S Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ORPHPRNewsWire • 07/30/21
ORPHAZYME A/S CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Orphazyme A/S in the United States District Court for the Northern District of IllinoisPRNewsWire • 07/28/21
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Orphazyme A/S (ORPH)PRNewsWire • 07/28/21
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 07/27/21
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 07/26/21
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 07/23/21
ORPH Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Orphazyme A/S Investors of Class Action and Encourages Shareholders to Contact the FirmNewsfile Corp • 07/23/21
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 07/22/21
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 07/21/21
ORPH CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Orphazyme A/SNewsfile Corp • 07/20/21
